
Data on the comparative merits of drugs recommended to manage heart failure (HF) are limited. A recent case-control study compared HF patients who died within 24 months of diagnosis with those who survived to 24 months after a HF diagnosis. The researchers compared the 2 groups to see which therapies…
Read more »
Beta blockers and cardiac resynchronization show greatest survival benefit for patients with heart failure
Data on the comparative merits of drugs recommended to manage heart failure (HF) are limited. A recent case-control study compared HF patients who died within 24 months of diagnosis with those who survived to 24 months after a HF diagnosis. The researchers compared the 2 groups to see which therapies…
Read more »